TG Therapeutics, Inc. (TGTX): Cash & Equivalents
$79.15M
As of 2025-12-31
$482.57M
As of 2026-06-30
-8.2%
3-year compound annual growth
-32.2%
5-year compound annual growth
+3.7%
10-year compound annual growth
| Period ended | Cash & Equivalents | Change YoY | Source filing |
|---|---|---|---|
| 2025-12-31 | $79.15M | -56.0% | 2026-02-27, Balance as of period end |
| 2024-12-31 | $179.89M | +93.6% | 2026-02-27, Balance as of period end |
| 2023-12-31 | $92.93M | -9.2% | 2026-02-27, Balance as of period end |
| 2022-12-31 | $102.30M | -65.8% | 2025-03-03, Balance as of period end |
| 2021-12-31 | $298.89M | -46.0% | 2024-02-29, Balance as of period end |
| 2020-12-31 | $553.44M | +391.3% | 2023-03-01, Balance as of period end |
| 2019-12-31 | $112.64M | +168.5% | 2022-03-01, Balance as of period end |
| 2018-12-31 | $41.96M | -26.0% | 2021-03-01, Balance as of period end |
| 2017-12-31 | $56.72M | +126.6% | 2020-03-02, Balance as of period end |
| 2016-12-31 | $25.03M | -54.5% | 2019-03-01, Balance as of period end |
| 2015-12-31 | $55.06M | -1.2% | 2018-03-15, Balance as of period end |
| 2014-12-31 | $55.71M | +37.6% | 2017-03-16, Balance as of period end |
| 2013-12-31 | $40.49M | +146.0% | 2016-03-15, Balance as of period end |
| 2012-12-31 | $16.46M | +68.8% | 2014-03-07, Balance as of period end |
| 2011-12-31 | $9.75M | n/a | 2014-03-07, Balance as of period end |
Cash & Equivalents at similar companies
| Company | Year ended | Cash & Equivalents | Change YoY |
|---|---|---|---|
| TG Therapeutics, Inc. (TGTX) | 2025-12-31 | $79.15M | -56.0% |
| Opko Health, Inc. (OPK) | 2025-12-31 | $364.41M | -14.6% |
| Insmed Inc (INSM) | 2025-12-31 | $510.44M | -8.0% |
| Axsome Therapeutics, Inc. (AXSM) | 2025-12-31 | $322.93M | +2.4% |
| Ultragenyx Pharmaceutical Inc. (RARE) | 2025-12-31 | $421.00M | +142.0% |
| Organogenesis Holdings Inc. (ORGO) | 2025-12-31 | $93.68M | -30.9% |
| Kiniksa Pharmaceuticals International, plc (KNSA) | 2025-12-31 | $165.60M | -9.8% |
| HUTCHMED (China) Ltd (HCM) | 2025-12-31 | $71.33M | -53.7% |
| Supernus Pharmaceuticals, Inc. (SUPN) | 2025-12-31 | $128.45M | +85.3% |
Compare TGTX, OPK, INSM, AXSM side by side · Screen every company in Pharmaceutical Preparations ↗